Ankylosing Spondylitis (AS)
Immunology·MeSH: Spondylitis, Ankylosing
Prevalence
310.0 / 100K
Incidence
7.3 / 100K/yr
6 drugs in development·6 companies·2 clinical trials
Drug Pipeline by Phase
Compare drugs
Frequently asked questions
How many drugs are in development for Ankylosing Spondylitis (AS)?
BioSniper tracks 6 drugs in development for Ankylosing Spondylitis (AS) across 6 companies.
How many clinical trials target Ankylosing Spondylitis (AS)?
There are 2 clinical trials targeting Ankylosing Spondylitis (AS) tracked by BioSniper.
What is the prevalence of Ankylosing Spondylitis (AS)?
The estimated prevalence of Ankylosing Spondylitis (AS) is approximately 310.0 per 100,000 population.
Deep-dive into Ankylosing Spondylitis (AS)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis